Key result
Epac1 deletion protected mice from cardiac dysfunction, apoptosis, and fibrosis induced by various stresses including pressure overload, chronic isoproterenol, and aging.
Why the study?
Does Epac1 deletion protect the heart from stress-induced cardiomyopathy and regulate cardiac contractility in mice?
Does Epac1 deletion protect the heart from stress-induced cardiomyopathy and regulate cardiac contractility in mice?
Answers are grounded in this paper and cite their sources.
Epac1 is a crucial regulator of PKA-independent phospholamban phosphorylation, and its deletion protects against stress-induced cardiomyopathy, highlighting it as a potential therapeutic target.
PKA phosphorylates multiple molecules involved in calcium (Ca2+) handling in cardiac myocytes and is considered to be the predominant regulator of β-adrenergic receptor-mediated enhancement of cardiac contractility; however, recent identification of exchange protein activated by cAMP (EPAC), which is independently activated by cAMP, has challenged this paradigm. Mice lacking Epac1 (Epac1 KO) exhibited decreased cardiac contractility with reduced phospholamban (PLN) phosphorylation at serine-16, the major PKA-mediated phosphorylation site. In Epac1 KO mice, intracellular Ca2+ storage and the magnitude of Ca2+ movement were decreased; however, PKA expression remained unchanged, and activation of PKA with isoproterenol improved cardiac contractility. In contrast, direct activation of EPAC in cardiomyocytes led to increased PLN phosphorylation at serine-16, which was dependent on PLC and PKCε. Importantly, Epac1 deletion protected the heart from various stresses, while Epac2 deletion was not protective. Compared with WT mice, aortic banding induced a similar degree of cardiac hypertrophy in Epac1 KO; however, lack of Epac1 prevented subsequent cardiac dysfunction as a result of decreased cardiac myocyte apoptosis and fibrosis. Similarly, Epac1 KO animals showed resistance to isoproterenol- and aging-induced cardiomyopathy and attenuation of arrhythmogenic activity. These data support Epac1 as an important regulator of PKA-independent PLN phosphorylation and indicate that Epac1 regulates cardiac responsiveness to various stresses.
No takes yet. Share an insight, caveat, or question.
Okumura et al. (2014) studied Cardiac stress response and heart failure. Epac1 deletion vs. Wild-type mice was evaluated on Left ventricular ejection fraction (LVEF) at 3 weeks after aortic banding (p=<0.01). Epac1 deletion protected mice from cardiac dysfunction, apoptosis, and fibrosis induced by various stresses including pressure overload, chronic isoproterenol, and aging.
Synapse has enriched 10 related papers. Consider them for comparative context: